Study Status
Show Details
Nickname
OAK-38
Status
Active
Site Activation
145 / 150 (96.7%)
Participant Enrollment
763 / 1000 (76.3%)
Studyid
AA-AA-000-0000
Nickname
OAK-38
Protocol Title
Protocol Title P
Status
Active
Num Plan Site
150
Num Plan Subj
1000
Act Fpfv
2012-01-02
Est Fpfv
2012-01-07
Est Lplv
2012-07-24
Est Lpfv
2012-03-26
Therapeutic Area
Virology
Protocol Indication
Hematology
Phase
P2
Product
Product Name 14
Site Target
150
Participant Target
1000
Participants Enrolled
763
Sites Enrolled
145
Percent Sites Activated
96.7
Site Activation
145 / 150 (96.7%)
Percent Participants Enrolled
76.3
Participant Enrollment
763 / 1000 (76.3%)
Study Overview
As of 2025-04-01, AA-AA-000-0000 has 763 participants enrolled across 3
countries. 1 Country-KRI combinations have been flagged across 1
countries as shown in the Study Overview Table above.
0 countries have at least one red KRI
1 countries have at least one red or amber KRI
2 countries have neither red nor amber KRIs
Missing delta columns in dfResults: Flag_Change, Flag_Previous,
Score_Change, Score_Previous, Numerator_Previous, Denominator_Previous,
Metric_Previous . Not rendering list of newly changed flags.NULL
Results
Adverse Event Rate
Serious Adverse Event Rate
Non-Important Protocol Deviation Rate
Important Protocol Deviation Rate
Grade 3+ Lab Abnormality Rate
Study Discontinuation Rate
Treatment Discontinuation Rate
Query Rate
Delayed Query Resolution Rate
Delayed Data Entry Rate
Data Change Rate
Screen Failure Rate
PK Collection Compliance Rate
Metric Details
Type
ID
GroupLevel
Abbreviation
Metric
Numerator
Denominator
Model
AnalysisType
Score
Threshold
AccrualThreshold
AccrualMetric
Priority
Flag
MetricID
Analysis
cou0001
Country
AE
Adverse Event Rate
Adverse Events
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-2,-1,2,3
30
Denominator
0
NA
Analysis_cou0001
Analysis
cou0002
Country
SAE
Serious Adverse Event Rate
Serious Adverse Events
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-2,-1,2,3
30
Denominator
0
NA
Analysis_cou0002
Analysis
cou0003
Country
PD
Non-Important Protocol Deviation Rate
Non-Important Protocol Deviations
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-3,-2,2,3
30
Denominator
0
NA
Analysis_cou0003
Analysis
cou0004
Country
IPD
Important Protocol Deviation Rate
Important Protocol Deviations
Days on Study
Normal Approximation
rate
Adjusted Z-Score
-3,-2,2,3
30
Denominator
0
NA
Analysis_cou0004
Analysis
cou0005
Country
LB
Grade 3+ Lab Abnormality Rate
Grade 3+ Abnormal Labs Samples
Total Lab Samples
Normal Approximation
binary
Adjusted Z-Score
2,3
10
Numerator
0
0,1,2
Analysis_cou0005
Analysis
cou0006
Country
SDSC
Study Discontinuation Rate
Subjects Discontinued - Study
Enrolled Subjects
Normal Approximation
binary
Adjusted Z-Score
2,3
3
Numerator
0
0,1,2
Analysis_cou0006
Analysis
cou0007
Country
TDSC
Treatment Discontinuation Rate
Subjects Discontinued - Treatment
Enrolled Subjects
Normal Approximation
binary
Adjusted Z-Score
2,3
3
Numerator
0
0,1,2
Analysis_cou0007
Analysis
cou0008
Country
QRY
Query Rate
Queries
Total Data Points
Normal Approximation
rate
Adjusted Z-Score
2,3
30
Numerator
0
0,1,2
Analysis_cou0008
Analysis
cou0009
Country
OQRY
Delayed Query Resolution Rate
Queries That Were Open > 30 Days
Total Queries
Normal Approximation
binary
Adjusted Z-Score
2,3
30
Numerator
0
0,1,2
Analysis_cou0009
Analysis
cou0010
Country
ODAT
Delayed Data Entry Rate
Data Pages Entered > 10 Days
Total Data Pages
Normal Approximation
binary
Adjusted Z-Score
2,3
30
Numerator
0
0,1,2
Analysis_cou0010
Analysis
cou0011
Country
CDAT
Data Change Rate
Data Points with 1+ Change
Total Data Points
Normal Approximation
binary
Adjusted Z-Score
2,3
100
Numerator
0
0,1,2
Analysis_cou0011
Analysis
cou0012
Country
SF
Screen Failure Rate
Screen Failures
Screened Subjects
Normal Approximation
binary
Adjusted Z-Score
-3,-2,2,3
3
Denominator
0
NA
Analysis_cou0012
Analysis
cou0013
Country
PK
PK Collection Compliance Rate
PK Samples Collected
PK Samples Expected
Identity
identity
PK Collection Compliance Rate
0.9,0.85
3
Difference
0
-2,-1,0
Analysis_cou0013